Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999501 | Urologic Oncology: Seminars and Original Investigations | 2015 | 6 Pages |
Abstract
The development of CDI occurs in 8.8% of patients undergoing RC. Our study demonstrates that use of chronic antacid therapy and long duration of antimicrobial exposure are associated with development of CDI. Efforts focusing on minimizing antibiotic exposure in patients undergoing RC are needed, and perioperative antimicrobial prophylaxis guidelines should be followed.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nick W. M.D., Kashyap M.D., M. Francesca M.D., M.P.H., Hristos Z. M.D., Clint M.D., M.P.H., Ronald S. M.D., Matthew J. M.D., Timothy A. M.D., Richard S. M.D., Thomas A. M.D., Richard M.D., Michael G. M.D., Michael O. M.D.,